Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Stomach Neoplasms × relatlimab × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

Oxaliplatin 73 S 1 (combination) 50 Capecitabine 38 apatinib 31 Paclitaxel 30 Docetaxel 29 Irinotecan 26 Drug Therapy 22 Fluorouracil 19 sintilimab 17 Cisplatin 15 Leucovorin 14 XELOX 11 Surgical Procedures, Operative 11 Hyperthermic Intraperitoneal Chemotherapy 11 camrelizumab 9 Trastuzumab 8 Tegafur 8 Nivolumab 8 Neoadjuvant Therapy 8 Laparoscopy 8 toripalimab 7 Ramucirumab 7 Gastrectomy 7 Chemotherapy, Adjuvant 7 titanium silicide 6 Gastroscopy 6 tislelizumab 5 pembrolizumab 5 gimeracil 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04062656 2024-03-12

IMAGINE

University Hospital, Essen

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡